HCC 22: Bladder, Colorectal, and Other Cancers ICD-10-CM
CMS-HCC Category 22 (Bladder, Colorectal, and Other Cancers) is a payment HCC in the V28 Medicare Advantage risk adjustment model. For payment year 2026 it adds a risk adjustment factor between 0.314 and 0.410 to a beneficiary's RAF score depending on the payment segment (0.363 for a community, non-dual, aged enrollee). 126 ICD-10-CM diagnosis codes map to HCC 22. A more severe related category (HCC 17, HCC 18, HCC 19, HCC 20, and HCC 21) supersedes it when both are reported.
RAF Weight by Payment Segment 7 segments
| Payment Segment | Relative Factor |
|---|---|
| Community, non-dual, aged | 0.363 |
| Community, partial-benefit dual, aged | 0.410 |
| Community, full-benefit dual, aged | 0.382 |
| Community, non-dual, disabled | 0.366 |
| Community, partial-benefit dual, disabled | 0.351 |
| Community, full-benefit dual, disabled | 0.409 |
| Institutional | 0.314 |
A beneficiary is scored in exactly one segment, set by Medicaid (dual) status, aged or disabled entitlement, and residence. Factors are relative weights, not dollar amounts; new-enrollee segments score on demographics only. In the hierarchy, HCC 17 (Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic), HCC 18 (Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid), HCC 19 (Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers), HCC 20 (Lung and Other Severe Cancers), and HCC 21 (Lymphoma and Other Cancers) supersede HCC 22 when reported together. HCC 22 in turn supersedes HCC 23 (Prostate, Breast, and Other Cancers and Tumors).
ICD-10-CM Codes That Map to HCC 22 126 codes
- C18.0 Malignant neoplasm of cecum from V24 HCC 11
- C18.1 Malignant neoplasm of appendix from V24 HCC 11
- C18.2 Malignant neoplasm of ascending colon from V24 HCC 11
- C18.3 Malignant neoplasm of hepatic flexure from V24 HCC 11
- C18.4 Malignant neoplasm of transverse colon from V24 HCC 11
- C18.5 Malignant neoplasm of splenic flexure from V24 HCC 11
- C18.6 Malignant neoplasm of descending colon from V24 HCC 11
- C18.7 Malignant neoplasm of sigmoid colon from V24 HCC 11
- C18.8 Malignant neoplasm of overlapping sites of colon from V24 HCC 11
- C18.9 Malignant neoplasm of colon, unspecified from V24 HCC 11
- C19 Malignant neoplasm of rectosigmoid junction from V24 HCC 11
- C20 Malignant neoplasm of rectum from V24 HCC 11
- C21.0 Malignant neoplasm of anus, unspecified from V24 HCC 11
- C21.1 Malignant neoplasm of anal canal from V24 HCC 11
- C21.2 Malignant neoplasm of cloacogenic zone from V24 HCC 11
- C21.8 Malignant neoplasm of overlapping sites of rectum, anus and anal canal from V24 HCC 11
- C26.0 Malignant neoplasm of intestinal tract, part unspecified from V24 HCC 11
- C26.1 Malignant neoplasm of spleen from V24 HCC 11
- C26.9 Malignant neoplasm of ill-defined sites within the digestive system from V24 HCC 11
- C51.0 Malignant neoplasm of labium majus from V24 HCC 11
- C51.1 Malignant neoplasm of labium minus from V24 HCC 11
- C51.2 Malignant neoplasm of clitoris from V24 HCC 11
- C51.8 Malignant neoplasm of overlapping sites of vulva from V24 HCC 11
- C51.9 Malignant neoplasm of vulva, unspecified from V24 HCC 11
- C52 Malignant neoplasm of vagina from V24 HCC 11
- C53.0 Malignant neoplasm of endocervix from V24 HCC 11
- C53.1 Malignant neoplasm of exocervix from V24 HCC 11
- C53.8 Malignant neoplasm of overlapping sites of cervix uteri from V24 HCC 11
- C53.9 Malignant neoplasm of cervix uteri, unspecified from V24 HCC 11
- C56.1 Malignant neoplasm of right ovary from V24 HCC 10
- C56.2 Malignant neoplasm of left ovary from V24 HCC 10
- C56.3 Malignant neoplasm of bilateral ovaries from V24 HCC 10
- C56.9 Malignant neoplasm of unspecified ovary from V24 HCC 10
- C57.00 Malignant neoplasm of unspecified fallopian tube from V24 HCC 10
- C57.01 Malignant neoplasm of right fallopian tube from V24 HCC 10
- C57.02 Malignant neoplasm of left fallopian tube from V24 HCC 10
- C57.10 Malignant neoplasm of unspecified broad ligament from V24 HCC 10
- C57.11 Malignant neoplasm of right broad ligament from V24 HCC 10
- C57.12 Malignant neoplasm of left broad ligament from V24 HCC 10
- C57.20 Malignant neoplasm of unspecified round ligament from V24 HCC 10
- C57.21 Malignant neoplasm of right round ligament from V24 HCC 10
- C57.22 Malignant neoplasm of left round ligament from V24 HCC 10
- C57.3 Malignant neoplasm of parametrium from V24 HCC 10
- C57.4 Malignant neoplasm of uterine adnexa, unspecified from V24 HCC 10
- C57.7 Malignant neoplasm of other specified female genital organs from V24 HCC 11
- C57.8 Malignant neoplasm of overlapping sites of female genital organs from V24 HCC 11
- C57.9 Malignant neoplasm of female genital organ, unspecified from V24 HCC 11
- C58 Malignant neoplasm of placenta from V24 HCC 10
- C64.1 Malignant neoplasm of right kidney, except renal pelvis from V24 HCC 11
- C64.2 Malignant neoplasm of left kidney, except renal pelvis from V24 HCC 11
- C64.9 Malignant neoplasm of unspecified kidney, except renal pelvis from V24 HCC 11
- C65.1 Malignant neoplasm of right renal pelvis from V24 HCC 11
- C65.2 Malignant neoplasm of left renal pelvis from V24 HCC 11
- C65.9 Malignant neoplasm of unspecified renal pelvis from V24 HCC 11
- C66.1 Malignant neoplasm of right ureter from V24 HCC 11
- C66.2 Malignant neoplasm of left ureter from V24 HCC 11
- C66.9 Malignant neoplasm of unspecified ureter from V24 HCC 11
- C67.0 Malignant neoplasm of trigone of bladder from V24 HCC 11
- C67.1 Malignant neoplasm of dome of bladder from V24 HCC 11
- C67.2 Malignant neoplasm of lateral wall of bladder from V24 HCC 11
- C67.3 Malignant neoplasm of anterior wall of bladder from V24 HCC 11
- C67.4 Malignant neoplasm of posterior wall of bladder from V24 HCC 11
- C67.5 Malignant neoplasm of bladder neck from V24 HCC 11
- C67.6 Malignant neoplasm of ureteric orifice from V24 HCC 11
- C67.7 Malignant neoplasm of urachus from V24 HCC 11
- C67.8 Malignant neoplasm of overlapping sites of bladder from V24 HCC 11
- C67.9 Malignant neoplasm of bladder, unspecified from V24 HCC 11
- C68.0 Malignant neoplasm of urethra from V24 HCC 11
- C68.1 Malignant neoplasm of paraurethral glands from V24 HCC 11
- C68.8 Malignant neoplasm of overlapping sites of urinary organs from V24 HCC 11
- C68.9 Malignant neoplasm of urinary organ, unspecified from V24 HCC 11
- C74.00 Malignant neoplasm of cortex of unspecified adrenal gland from V24 HCC 10
- C74.01 Malignant neoplasm of cortex of right adrenal gland from V24 HCC 10
- C74.02 Malignant neoplasm of cortex of left adrenal gland from V24 HCC 10
- C74.10 Malignant neoplasm of medulla of unspecified adrenal gland from V24 HCC 10
- C74.11 Malignant neoplasm of medulla of right adrenal gland from V24 HCC 10
- C74.12 Malignant neoplasm of medulla of left adrenal gland from V24 HCC 10
- C74.90 Malignant neoplasm of unspecified part of unspecified adrenal gland from V24 HCC 10
- C74.91 Malignant neoplasm of unspecified part of right adrenal gland from V24 HCC 10
- C74.92 Malignant neoplasm of unspecified part of left adrenal gland from V24 HCC 10
- C91.10 Chronic lymphocytic leukemia of B-cell type not having achieved remission from V24 HCC 10
- C91.11 Chronic lymphocytic leukemia of B-cell type in remission from V24 HCC 10
- C91.12 Chronic lymphocytic leukemia of B-cell type in relapse from V24 HCC 10
- C91.40 Hairy cell leukemia not having achieved remission from V24 HCC 10
- C91.41 Hairy cell leukemia, in remission from V24 HCC 10
- C91.42 Hairy cell leukemia, in relapse from V24 HCC 10
- C91.90 Lymphoid leukemia, unspecified not having achieved remission from V24 HCC 10
- C91.91 Lymphoid leukemia, unspecified, in remission from V24 HCC 10
- C91.92 Lymphoid leukemia, unspecified, in relapse from V24 HCC 10
- C91.Z0 Other lymphoid leukemia not having achieved remission from V24 HCC 10
- C91.Z1 Other lymphoid leukemia, in remission from V24 HCC 10
- C91.Z2 Other lymphoid leukemia, in relapse from V24 HCC 10
- C92.10 Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission from V24 HCC 9
- C92.11 Chronic myeloid leukemia, BCR/ABL-positive, in remission from V24 HCC 9
- C92.12 Chronic myeloid leukemia, BCR/ABL-positive, in relapse from V24 HCC 9
- C92.40 Acute promyelocytic leukemia, not having achieved remission from V24 HCC 8
- C92.41 Acute promyelocytic leukemia, in remission from V24 HCC 8
- C92.42 Acute promyelocytic leukemia, in relapse from V24 HCC 8
- C95.10 Chronic leukemia of unspecified cell type not having achieved remission from V24 HCC 10
- C95.11 Chronic leukemia of unspecified cell type, in remission from V24 HCC 10
- C95.12 Chronic leukemia of unspecified cell type, in relapse from V24 HCC 10
- C95.90 Leukemia, unspecified not having achieved remission from V24 HCC 10
- C95.91 Leukemia, unspecified, in remission from V24 HCC 10
- C95.92 Leukemia, unspecified, in relapse from V24 HCC 10
- D3A.00 Benign carcinoid tumor of unspecified site new to V28
- D3A.010 Benign carcinoid tumor of the duodenum new to V28
- D3A.011 Benign carcinoid tumor of the jejunum new to V28
- D3A.012 Benign carcinoid tumor of the ileum new to V28
- D3A.019 Benign carcinoid tumor of the small intestine, unspecified portion new to V28
- D3A.020 Benign carcinoid tumor of the appendix new to V28
- D3A.021 Benign carcinoid tumor of the cecum new to V28
- D3A.022 Benign carcinoid tumor of the ascending colon new to V28
- D3A.023 Benign carcinoid tumor of the transverse colon new to V28
- D3A.024 Benign carcinoid tumor of the descending colon new to V28
- D3A.025 Benign carcinoid tumor of the sigmoid colon new to V28
- D3A.026 Benign carcinoid tumor of the rectum new to V28
- D3A.029 Benign carcinoid tumor of the large intestine, unspecified portion new to V28
- D3A.090 Benign carcinoid tumor of the bronchus and lung new to V28
- D3A.091 Benign carcinoid tumor of the thymus new to V28
- D3A.092 Benign carcinoid tumor of the stomach new to V28
- D3A.093 Benign carcinoid tumor of the kidney new to V28
- D3A.094 Benign carcinoid tumor of the foregut, unspecified new to V28
- D3A.095 Benign carcinoid tumor of the midgut, unspecified new to V28
- D3A.096 Benign carcinoid tumor of the hindgut, unspecified new to V28
- D3A.098 Benign carcinoid tumors of other sites new to V28
- D3A.8 Other benign neuroendocrine tumors new to V28
Every code above carries the full HCC 22 weight when documented and reported on a Medicare Advantage encounter. The code link opens its full page with the complete risk adjustment card.
Questions About HCC 22
What is HCC 22 in the CMS-HCC model?
HCC 22 is CMS-HCC Category 22 (Bladder, Colorectal, and Other Cancers) in the V28 risk adjustment model. It covers 126 ICD-10-CM diagnosis codes that raise a Medicare Advantage beneficiary's risk score when documented.
What is the RAF weight for HCC 22?
For payment year 2026, HCC 22 adds 0.363 to the RAF score of a community, non-dual, aged beneficiary. The published weights range from 0.314 to 0.410 across the seven payment segments shown above.
Which categories supersede HCC 22?
HCC 17 (Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic), HCC 18 (Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid), HCC 19 (Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers), HCC 20 (Lung and Other Severe Cancers), and HCC 21 (Lymphoma and Other Cancers) sit above HCC 22 in the hierarchy: when a beneficiary has diagnoses in both, only the more severe category is paid.
Related References
Source: Centers for Medicare & Medicaid Services, Payment Year 2026 risk adjustment mapping and model software releases (CMS-HCC V28), applied to the FY 2026 ICD-10-CM code set. ICD List is not affiliated with CMS.
